IGM Biosciences Inc. (IGMS) Acquired by Concentra Biosciences for $1.247/sh Cash Plus CVR Jul 1, 2025 08:59AM
Stifel Reiterates Hold Rating on IGM Biosciences (IGMS) Mar 7, 2025 09:09AM
IGM Biosciences (IGMS) PT Slashed to $2 at Truist Securities Following Autoimmune Failure Jan 10, 2025 10:38AM
Morgan Stanley Downgrades IGM Biosciences (IGMS) to Underweight Jan 10, 2025 05:18AM
RBC Capital Downgrades IGM Biosciences (IGMS) to Sector Perform Jan 10, 2025 12:21AM


Jan 10, 2025 12:21AM Stifel Downgrades IGM Biosciences (IGMS) to Hold
Jan 10, 2025 12:21AM BMO Capital Downgrades IGM Biosciences (IGMS) to Market Perform
Dec 5, 2024 04:05PM BMO Capital Starts IGM Biosciences (IGMS) at Outperform
Nov 8, 2024 07:34AM IGM Biosciences Inc. (IGMS) Misses Q3 EPS by 21c
Oct 18, 2024 07:05AM IGM Biosciences (IGMS) PT Raised to $20 at RBC Capital
Oct 1, 2024 06:55AM Stifel Reiterates Buy Rating on IGM Biosciences (IGMS)
Oct 1, 2024 06:52AM Truist Securities Downgrades IGM Biosciences (IGMS) to Hold
Oct 1, 2024 06:32AM IGM Biosciences (IGMS) PT Lowered to $17 at RBC Capital
Oct 1, 2024 06:16AM Jefferies Reiterates Buy Rating on IGM Biosciences (IGMS)
Oct 1, 2024 06:09AM Morgan Stanley Reiterates Equalweight Rating on IGM Biosciences (IGMS)
Oct 1, 2024 05:52AM JPMorgan Downgrades IGM Biosciences (IGMS) to Underweight
Sep 30, 2024 05:01PM After-hours movers: IGM Biosciences, Biohaven Pharma, Acadia Realty Trust
Sep 30, 2024 04:13PM IGM Biosciences (IGMS) Announces Strategic Pivot to Focus Exclusively on Autoimmunity
Sep 30, 2024 04:13PM IGM Biosciences Inc. (IGMS) Falls 27% After Announcing Plans to Prioritize its Pipeline of T Cell Engagers
Sep 5, 2024 06:37AM IGM Biosciences (IGMS) PT Lowered to $11 at H.C. Wainwright
Aug 14, 2024 12:04PM Morgan Stanley Reiterates Overweight Rating on IGM Biosciences (IGMS)
Aug 14, 2024 09:42AM IGM Biosciences Inc. (IGMS) Misses Q2 EPS by 75c; offers guidance